Congo vs Tuvalu: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Tuvalu
100.0%
in 2021
Congo rank
1st
Tuvalu rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Tuvalu
How they compare
Congo currently reports 100.0% against 100.0% in Tuvalu, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2014 it was Congo ahead.
Congo ranks 1st and Tuvalu ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Tuvalu in 1.
Head to head by decade
| Decade | Congo | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.3% | 26.7% | 64.7% | Congo |
| 2020s | 24.5% | 100.0% | 75.5% | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Tuvalu?
- Congo, at 100.0% against 100.0% in Tuvalu as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Tuvalu?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Tuvalu?
- 5 years are reported by both, from 2014 to 2021.
- How do Congo and Tuvalu rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Tuvalu ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.